StonvexLoading…
StonvexCore line items from UPST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2023 2023-09-30 | Q2 2023 2023-06-30 | Q1 2023 2023-03-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $407.58M | $260.83M | $117.14M | $907.27M |
Operating Income | $-209.02M | $-165.18M | $-131.84M | $-113.86M |
Net Income | $-197.73M | $-157.42M | $-129.25M | $-108.67M |
EPS (Diluted) | $-2.38 | $-1.91 | $-1.58 | $-1.31 |
Total Assets | $2.00B | $1.76B | $1.82B | $1.94B |
Total Liabilities | $1.36B | $1.13B | $1.19B | $1.26B |
Cash & Equivalents | $615.03M | $509.89M | $451.86M | $532.47M |
Free Cash Flow OCF − CapEx | $32.60M | $140.45M | $-76.84M | $-666.68M |
Shares Outstanding | 85.02M | 83.81M | 82.60M | 81.26M |